Treatment for Inflammatory Bowel Diseases

1 Prior Treatment
Waitlist Available · < 65 · All Sexes · Philadelphia, PA

This study is evaluating whether fecal transplantation is safe and effective for treating recurrent C. Difficile in children.

See full description

About the trial for Inflammatory Bowel Diseases

Eligible Conditions
Ulcerative Colitis · Crohn Disease · Inflammatory Bowel Diseases (IBD) · Clostridium Difficile · Colitis, Ulcerative · Inflammatory Bowel Diseases · Crohn's Disease (CD)

Treatment Groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.


This trial is for patients born any sex aged 65 and younger. You must have received 1 prior treatment for Inflammatory Bowel Diseases or one of the other 6 conditions listed above. There are 6 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
According to standard protocol, a colonoscopy, radiographic, and clinic measures are used to diagnose Inflammatory Bowel Disease. show original
The person must be at least 3 years old. show original
Recurrent C. difficile or Moderate to Severe C. difficile.
Satisfactory completion of the medical interview and physical exam conducted by a study team member
on the day of the Drawing To be eligible to participate in the drawing, you must be aged between 3 and 21 inclusive on the day of the drawing. show original
Signed informed consent form, and assent (if applicable)
View All
Odds of Eligibility
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 7 days
Screening: ~3 weeks
Treatment: Varies
Reporting: 7 days
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 7 days.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Inflammatory Bowel Diseases. Measurement will happen over the course of 7 days.

Number of subjects with a recurrence of C. difficile (CDI)
The hypothesis is that FMT will be an effective therapy for patients with IBD and CDI, resulting in resolution of symptoms as compared to historical controls on antibiotic therapy.

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people get inflammatory bowel diseases a year in the United States?

Most of the people who get an inflammatory bowel disease encounter it between the ages of 18 and 50. The disease is more common in women than men and in whites than minorities. Power makes it easy to find IBD clinical trials tailored to your condition, type of disease, and location.

Anonymous Patient Answer

What are the signs of inflammatory bowel diseases?

If patients presenting with unexplained IBD symptoms present with signs of diarrhea or a change in bowel habit, they may have intestinal tuberculosis. Other signs of IBD include abdominal pain, constipation, unexplained weight loss or malaise. IBD is a type of inflammatory bowel disease.\n

Anonymous Patient Answer

What is inflammatory bowel diseases?

IBD can present as an inflammatory and autoimmune disorder that has numerous presentations. IBD often begins in childhood and continues on through a person's life. It is important for a person's doctor to know what presentations and presentations, if any, the patient might display.\n

Anonymous Patient Answer

What are common treatments for inflammatory bowel diseases?

Crohn's disease and ulcerative colitis are both treated with antibiotics and are most often symptomatic, but often require surgery. The number of IBD patients and their families are growing every day. It is important to be aware of all options and to discuss the possibility for all patients to be involved in decisions about treating their IBD.

Anonymous Patient Answer

What causes inflammatory bowel diseases?

Many autoimmune illnesses, allergies, and certain environmental factors may cause inflammatory bowel diseases. They are a group of painful intestinal disorders, which include chronic colitis, Crohn's disease, or ulcerative colitis, and they are associated with an increased risk of early death from colorectal cancer.

Anonymous Patient Answer

Can inflammatory bowel diseases be cured?

Patients with IBD have a high mortality because of the complications of the disease. With careful care, most patients can maintain normal lives without any sign of the disease, with only a few having minor symptoms.

Anonymous Patient Answer

What are the common side effects of treatment?

Treatment of ulcerative colitis and Crohn's disease can be challenging due to the high probability of serious disease flares and the relatively unbalanced nature of long-term treatment. Although severe side effects occur infrequently, the side effects encountered should be considered when treatment decisions are made.\n

Anonymous Patient Answer

What does treatment usually treat?

There is now an opportunity to exploit the high prevalence of inflammatory bowel disease among people who live on remote islands and to provide evidence-based treatment approaches to manage these diseases at all stages of life.

Anonymous Patient Answer

What is treatment?

A treatment protocol for question: Is question: Is patient reported outcome measures an accurate measure of satisfaction after gastrostomy insertion? answer: Patient reported and nurse observed satisfaction data may not be interchangeable. This implies that gastrostomies cannot replace quality of life measures in the assessment of GI patient satisfaction in standard clinical practice. However, gastrostomy should be considered an adjunct to the clinical assessment of patients with gastrointestinal conditions.

Anonymous Patient Answer

Have there been any new discoveries for treating inflammatory bowel diseases?

There has been some new discoveries for treating inflammatory bowel disease. However, the use of immunosuppressants and immunosuppressive drugs are not devoid of unwanted side effects and patients should be advised in the best way to manage their symptoms. The number of therapeutic options for treating inflammatory bowel disease is limited.

Anonymous Patient Answer

Has treatment proven to be more effective than a placebo?

As of today, the results from placebo-controlled trials and meta-analyses of placebo-controlled trials provide evidence that placebo is more effective than no treatment for several types of inflammatory bowel diseases.

Anonymous Patient Answer

What is the latest research for inflammatory bowel diseases?

The use of innovative ways to detect and treat IBD is growing rapidly and many exciting results have come from research underway from across the IBD and other areas of medicine. This rapid acceleration of discovery will ultimately lead to further improvements in the lives of patients.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Inflammatory Bowel Diseases by sharing your contact details with the study coordinator.